A Comprehensive Program to Reduce Tobacco-related Cancers Through Actions by a National Cancer Institute-designated Cancer Center

被引:3
|
作者
Cofer, Jennifer [1 ,5 ]
Hurst, Alex N. [1 ]
Winter, Tiffany [1 ]
Moreno, Mark [2 ]
Cinciripini, Paul M. [1 ]
Walsh Jr, Michael T. [3 ]
Tektiridis, Jennifer [4 ]
Hawk, Ernest [4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Govt Relat, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Canc Prevent & Control Platform, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Houston, TX USA
[5] Univ TexasMD Anderson Canc Ctr, Dept Behav Sci, 1155 Pressler Dr, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
cancer prevention; health systems change; cancer control; tobacco control; tobacco prevention; tobacco treatment; provider tobacco training; UNITED-STATES; ADULTS;
D O I
10.1177/10732748221138713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tobacco use accounts for 30% of all cancer-related deaths worldwide and 20% in the US, despite effective, evidence-based interventions for reducing tobacco use and tobacco-related cancers and deaths. In 2012, to reduce the burden of tobacco-related cancer and associated population-level risks across Texas, The University of Texas MD Anderson Cancer Center initiated the EndTobacco((R)) program to promote statewide cancer control activities. We created evidence-based initiatives, established selection criteria, and implemented actions involving policy, education, and tobacco treatment services. As a result, EndTobacco has supported, educated, and convened local and state coalitions in policymaking; provided tobacco treatment education to health professionals; implemented Texas' only certified tobacco treatment training program; and led an initiative to enhance the tobacco-free culture of the state's publicly funded university system. Supported by commitments from MD Anderson, we developed and implemented evidence-based actions for tobacco control tailored to the center's mission, values, expertise, resources, and partnerships. By 2021, the adult smoking rate in Texas dropped from 19.2% (2014) to 13.2%. Contributors to this drop include state tobacco control policies, programs and services from multiple agencies and associations, and EndTobacco activities that complement the statewide effort to prevent youth smoking initiation and increase quit attempts among youth and adults.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute-designated cancer center
    Westergaard, Sarah A.
    Rupji, Manali
    Franklin, Lauren E.
    Behera, Madhusmita
    Ramalingam, Suresh S.
    Higgins, Kristin A.
    CANCER MEDICINE, 2023, 12 (06): : 7339 - 7347
  • [2] Management of Occult Primary Breast Cancer at a National Cancer Institute-Designated Comprehensive Cancer Center
    Fayanju, Oluwadamilola
    Jeffe, Donna
    Margenthaler, Julie
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 40 - 40
  • [3] Oncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer center
    Bakitas, Marie
    Lyons, Kathleen Doyle
    Hegel, Mark T.
    Ahles, Tim
    PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (05) : 415 - 423
  • [4] Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center
    Liang, Margaret I.
    ElNaggar, Adam C.
    Nekkanti, Silpa
    O'Malley, David M.
    Hade, Erinn M.
    Copeland, Larry J.
    Fowler, Jeffrey M.
    Salani, Ritu
    Backes, Floor J.
    Cohn, David E.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 689 - 693
  • [5] Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center
    Furlan, Julio C.
    Furlan, Daniel T.
    Marquez-Chin, Cesar
    JCO ONCOLOGY PRACTICE, 2022, 18 (02) : 184 - 190
  • [6] Improving the Time to Activation of New Clinical Trials at a National Cancer Institute-Designated Comprehensive Cancer Center
    Williams, Erin
    Brown, Timothy J.
    Griffith, Patrice
    Rahimi, Asal
    Oilepo, Rhonda
    Hammers, Hans
    Laetsch, Theodore W.
    Currykosky, Penny
    Partridge, Susan
    Beg, Muhammad S.
    JCO ONCOLOGY PRACTICE, 2020, 16 (04) : 166 - +
  • [7] Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center
    Mansur, David B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1001 - 1005
  • [8] Cancer disparities among sexual and gender minority patients at a National Cancer Institute-Designated Comprehensive Cancer Center
    Zamani, Shahrzad A.
    Perez-Morales, Jaileene
    Miller, Jarred D.
    Schabath, Matthew B.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center
    Miller, Kenneth
    Mehta, Rutika
    Abraham, Joseph
    Opneja, Aman
    Jain, Rohit K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (06): : 639 - 643
  • [10] Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center
    Jain, Neha M.
    Schmalz, Lauren
    Cann, Christopher
    Holland, Adara
    Osterman, Travis
    Lang, Katie
    Wiesner, Georgia L.
    Pal, Tuya
    Lovly, Christine
    Stricker, Thomas
    Micheel, Christine
    Balko, Justin M.
    Johnson, Douglas B.
    Park, Ben Ho
    Iams, Wade
    ONCOLOGIST, 2021, 26 (11): : E1962 - E1970